2/28/2023 0 Comments Ambify drug![]() ![]() This medication may, in fact, cause people to lose control over their impulses. However, the manufacturers never warned the public, including the doctors who prescribed it, about the dangers posed by Abilify. It is manufactured by a Japanese corporation, Otsuka Pharmaceutical, together with the American Bristol-Myers Squibb (BMS).Īll drugs pertaining to the atypical antipsychotic class are inherently dangerous and associated with numerous side effects such as hyperlipidemia, eye disorders, and weight gain. market by the Food and Drug Administration (FDA) in 2002. ![]() It acts by normalizing the production of important neurotransmitters in the brain such as serotonin and dopamine. We can also provide you with legal assistance if you or your children took this medication during childhood and later developed type-2 diabetes.Ĭall us now or fill our form for a free legal consultation.Ībilify (aripiprazole) is an antipsychotic drug used for the management of schizophrenia, depression, autistic disorder, and mood disorders. Our team will help you contact the best lawyers available to assist you in your legal battle. If you or one of your beloved ones lost a considerable sum of money due to pathological gambling or showed any other sign of compulsive behaviors after taking Abilify, you should seek monetary compensation in court. The pharmaceutical companies are facing legal claims by dozens of individuals who allege that the drug caused them to lose thousands of dollars or harmed their children. According to the ongoing mass tort litigation, the manufacturer Bristol-Myers Squibb and Otsuka Pharmaceutical failed to warn patients that the antipsychotic medication may increase the risk of compulsive gambling and type-2 diabetes in children. Patients who took the antipsychotic Abilify are filing a lawsuit after they developed compulsive behaviors that led them into gambling or other addictions. The FDA has received at least 184 reports of impulse-control disorders since Abilify was approved in 2002.Home /Abilify Lawsuit 2022 Abilify Lawsuit 2022 Abilify Lawsuit 2022 Pathological gambling was already listed as a reported side effect of Abilify, but the FDA required the drug label to be modified to include additional compulsive behaviors, including compulsive eating, shopping, and sexual actions. In May of 2016, the FDA released a Safety Communication warning about impulse-control problems associated with this drug. Researchers found a link between gambling in seven of the eight patients. Then in 2013, a study in Addictive Behaviors analyzed data from eight cases of Abilify users and pathological gambling. The study also noted that existing literature had observed other cases of developing or worsening obsessive disorder, including hypersexuality and excessive shopping. In July of 2011, a study in The British Journal of Psychiatry linked pathological gambling to aripiprazole use. As of 2013, Abilify had annual sales of $7 billion. It was later approved to treat bipolar disorder, major depression, Tourette’s syndrome, and autism. The FDA approved the drug in 2002 for the treatment of schizophrenia. Abilify, or aripiprazole, is an atypical antipsychotic that was first developed by Otsuka in Japan, and now marketed by Bristol-Myers Squibb in the United States.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |